2m 2m 2m 2m 2m 2m 2m
QScreen (PMEDF)
OTC
$0.03+$0.001 (+4.56%)
Price as of Jun 03, 2026- $6.3MMarket Cap
- 41.13%1-Year Change
- Medical DevicesIndustry
QScreen (PMEDF)
$0.03+$0.001 (+4.56%)
Annual
Quarterly
01/31/2023 | 01/31/2022 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 35,020 -74.02% | 134,820 N/A | |
Cost of Revenue | 8,400 -83.20% | 50,000 N/A | |
Gross Profit | 26,620 -68.62% | 84,820 N/A | |
Sales and Marketing Expense | 294,056 -42.18% | 508,609 N/A | |
Research and Development Expense | -82,600 +13.33% | -72,885 N/A | |
Depreciation and Amortization Expense | 159,455 +101.11% | 79,288 N/A | |
Total Operating Expenses | 89,434 +168.18% | 33,349 N/A | |
Operating Profit | N/A N/A | N/A N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | -2,870 N/A | 0 N/A | |
Interest Income and Expense and Net | -2,870 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 2,870 N/A | 0 N/A | |
Income before Taxes | -2.1M +9.86% | -1.9M N/A | |
Income Taxes | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | -2.1M +9.86% | -1.9M N/A | |
Net Income from Continuing Operations Applicable to Common | -2.1M +9.86% | -1.9M N/A | |
Basic EPS and Net Income | -0.02 N/A | N/A N/A | |
Diluted EPS and Net Income | -0.02 +5.88% | -0.02 N/A | |
Basic Weighted Average Shares | 114.2M +5.78% | 107.9M N/A | |
Diluted Weighted Average Shares | 114.2M +5.78% | 107.9M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 79,250 -62.49% | 211,302 N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 79,250 -62.49% | 211,302 N/A | |
Total Current Assets | 137,480 -78.57% | 641,624 N/A | |
Accumulated Depreciation | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 134,547 +76.44% | 76,255 N/A | |
Total Long-Term Assets | N/A N/A | N/A N/A | |
Total Assets | 717,735 -41.96% | 1.2M N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | |
Total Current Liabilities | 871,124 +149.13% | 349,672 N/A | |
Total Long-Term Debt | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | N/A N/A | N/A N/A | |
Total Liabilities | 871,124 +149.13% | 349,672 N/A | |
Retained Earnings | -8.1M +34.38% | -6.0M N/A | |
Total Stockholders Equity | -153,389 -117.29% | 886,985 N/A | |
Total Shares Outstanding | 122.1M +11.92% | 109.1M N/A | |
Cash Flow | |||
Cash from Operating Activities | -534,175 -65.14% | -1.5M N/A | |
Capital Expenditures | N/A N/A | N/A N/A | |
Cash from Investing Activities | -144,677 -65.40% | -418,123 N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | 546,800 -67.48% | 1.7M N/A | |
Financials Ratio | |||
Gross Margin | 76.01% N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | |
Return on Assets | -211.60% N/A | N/A N/A | |
Return on Equity | -563.73% N/A | N/A N/A | |
Revenue Growth | -74.02% N/A | N/A N/A | |
Current Ratio | 0.16 N/A | N/A N/A | |
Cash Ratio | 0.09 N/A | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow